| Dr Shilpa Lamba, MD | |
|
10 Members Way, Suite 402, Dover, NH 03820-5933 | |
| (603) 742-1444 | |
| (603) 742-1443 |
| Full Name | Dr Shilpa Lamba |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Experience | 19 Years |
| Location | 10 Members Way, Dover, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962649442 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 15447 (New Hampshire) | Secondary |
| 208800000X | Urology | 25MA08524000 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wentworth-douglass Hospital | Dover, NH | Hospital |
| Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
| Huggins Hospital | Wolfeboro, NH | Hospital |
| Exeter Hospital Inc | Exeter, NH | Hospital |
| York Hospital | York, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Core Physicians Llc | 2769563253 | 234 |
| Manchester Urology Associates Professional Association | 6406877760 | 21 |
News Archive
The updated guideline for estrogen and progesterone receptor (ER/PgR) testing in breast cancer, published jointly today by the College of American Pathologists and the American Society of Clinical Oncology, reaffirms much of the original guidance and has more specific recommendations for handling and reporting cases with low ER expression.
Adaptimmune announced today that it has opened a Pilot, open-label clinical trial in synovial sarcoma at the National Cancer Institute (NCI), Bethesda, Maryland, testing its enhanced T cell receptor T cell therapy. A second site is planned to open later this year at Washington University, St. Louis, Missouri.
Despite Uganda's national HIV prevention campaign that endorses the "ABC-plus" model – "which includes abstinence, being faithful and condom use, as well as measures to prevent the mother-to-child-transmission of HIV and, more recently, methods such as medical male circumcision" - many young Ugandans do not use condoms consistently during sex, "spurring new measures to promote the prophylactic," PlusNews reports.
PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE Amex: PHC), a leading provider of inpatient and outpatient behavioral health services, reported financial results for the company's fourth fiscal quarter and year ended June 30, 2009. The results exclude the operations of the company`s research division, Pivotal Research Centers, Inc. ("Pivotal"), which was sold during the 2009 third fiscal quarter and was classified as a discontinued operation.
› Verified 1 days ago
| Entity Name | Manchester Urology Associates Professional Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578660700 PECOS PAC ID: 6406877760 Enrollment ID: O20051214000467 |
News Archive
The updated guideline for estrogen and progesterone receptor (ER/PgR) testing in breast cancer, published jointly today by the College of American Pathologists and the American Society of Clinical Oncology, reaffirms much of the original guidance and has more specific recommendations for handling and reporting cases with low ER expression.
Adaptimmune announced today that it has opened a Pilot, open-label clinical trial in synovial sarcoma at the National Cancer Institute (NCI), Bethesda, Maryland, testing its enhanced T cell receptor T cell therapy. A second site is planned to open later this year at Washington University, St. Louis, Missouri.
Despite Uganda's national HIV prevention campaign that endorses the "ABC-plus" model – "which includes abstinence, being faithful and condom use, as well as measures to prevent the mother-to-child-transmission of HIV and, more recently, methods such as medical male circumcision" - many young Ugandans do not use condoms consistently during sex, "spurring new measures to promote the prophylactic," PlusNews reports.
PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE Amex: PHC), a leading provider of inpatient and outpatient behavioral health services, reported financial results for the company's fourth fiscal quarter and year ended June 30, 2009. The results exclude the operations of the company`s research division, Pivotal Research Centers, Inc. ("Pivotal"), which was sold during the 2009 third fiscal quarter and was classified as a discontinued operation.
› Verified 1 days ago
| Entity Name | Core Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336330588 PECOS PAC ID: 2769563253 Enrollment ID: O20080123000205 |
News Archive
The updated guideline for estrogen and progesterone receptor (ER/PgR) testing in breast cancer, published jointly today by the College of American Pathologists and the American Society of Clinical Oncology, reaffirms much of the original guidance and has more specific recommendations for handling and reporting cases with low ER expression.
Adaptimmune announced today that it has opened a Pilot, open-label clinical trial in synovial sarcoma at the National Cancer Institute (NCI), Bethesda, Maryland, testing its enhanced T cell receptor T cell therapy. A second site is planned to open later this year at Washington University, St. Louis, Missouri.
Despite Uganda's national HIV prevention campaign that endorses the "ABC-plus" model – "which includes abstinence, being faithful and condom use, as well as measures to prevent the mother-to-child-transmission of HIV and, more recently, methods such as medical male circumcision" - many young Ugandans do not use condoms consistently during sex, "spurring new measures to promote the prophylactic," PlusNews reports.
PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE Amex: PHC), a leading provider of inpatient and outpatient behavioral health services, reported financial results for the company's fourth fiscal quarter and year ended June 30, 2009. The results exclude the operations of the company`s research division, Pivotal Research Centers, Inc. ("Pivotal"), which was sold during the 2009 third fiscal quarter and was classified as a discontinued operation.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shilpa Lamba, MD 10 Members Way, Suite 402, Dover, NH 03820-5933 Ph: (603) 742-1444 | Dr Shilpa Lamba, MD 10 Members Way, Suite 402, Dover, NH 03820-5933 Ph: (603) 742-1444 |
News Archive
The updated guideline for estrogen and progesterone receptor (ER/PgR) testing in breast cancer, published jointly today by the College of American Pathologists and the American Society of Clinical Oncology, reaffirms much of the original guidance and has more specific recommendations for handling and reporting cases with low ER expression.
Adaptimmune announced today that it has opened a Pilot, open-label clinical trial in synovial sarcoma at the National Cancer Institute (NCI), Bethesda, Maryland, testing its enhanced T cell receptor T cell therapy. A second site is planned to open later this year at Washington University, St. Louis, Missouri.
Despite Uganda's national HIV prevention campaign that endorses the "ABC-plus" model – "which includes abstinence, being faithful and condom use, as well as measures to prevent the mother-to-child-transmission of HIV and, more recently, methods such as medical male circumcision" - many young Ugandans do not use condoms consistently during sex, "spurring new measures to promote the prophylactic," PlusNews reports.
PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE Amex: PHC), a leading provider of inpatient and outpatient behavioral health services, reported financial results for the company's fourth fiscal quarter and year ended June 30, 2009. The results exclude the operations of the company`s research division, Pivotal Research Centers, Inc. ("Pivotal"), which was sold during the 2009 third fiscal quarter and was classified as a discontinued operation.
› Verified 1 days ago
Eric Raffin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way, Dover, NH 03820 Phone: 603-742-1444 | |
Dr. Sandy Chin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way, Suite 402, Dover, NH 03820 Phone: 603-742-1444 Fax: 603-742-1443 | |
Egbert D Baumgart, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 17 Old Rollinsford Road, Suite 3, Dover, NH 03820 Phone: 608-742-5011 Fax: 603-742-3530 |